Company intelligence / Profile preview

Sandstone Diagnostics

Pleasanton, California, United Stateshypatiagroup.squarespace.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Sandstone Diagnostics has commercialized the Trak® Male Fertility Testing System, an FDA-cleared at-home diagnostic device that allows men to monitor sperm quality. The company is also developing a “zero delay plasma separation” technology for automated blood sample preparation at the point of collection, aiming to improve test sensitivity and reliability[6].

Therapeutic areas: Men's Health
Modalities: DeviceMicrofluidic device (for diagnostics)
Industry: Pathology

Beyond the preview

Go deeper on Sandstone Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sandstone Diagnostics.

Explore the full profile